Register to get unlimited access to our investor forum and all editorial content, including our e-zine and weekly email. Registration is free and only takes a minute.
Top Story

Trust buster Lazard World gets fatal taste of its own medicine

Trust buster Lazard World gets fatal taste of its own medicine

Buying stakes in under-loved investment trusts and closed-end funds was the speciality of Lazard World Trust but ironically its own shareholders fell out out of love with the discount hunter and have voted to end its 27-year tenure.